chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Joint stiffness progressing to a full flair-up of PMR. Effected knees, hips shoulders, jaw and hands. Treatment until 2 weeks after facing was controlling pain with Tramadol and anti-inflammatory with Dicofenac Sodium.  Was not effective in controlling joint stiffness associated with PMR . 12 days after vaccine began regiment of Prednisone beginning at 120mg per day and tapering off to 2 mg per day 5 week period. Effective while taking Prednisone. Stifness returned after completing Prednisone. Had shot of Torodol and another steroid. Effective for a few days. Went back (currently taking) Prednisone beginning with 10mg per day tapering to 2 over a 5 week period.
Fever 102'. 1 week later on 6/6/15 had another fever 100.-102. and has lasted 3 days and on 6/9/15 now has rash on trunk-appears to be measles.
From the left side of face to behind the left ear, down around the neck, and chest up to behind the right ear there is a red, raised and itchy rash.
Patient developed papuloerythrotelangiectatic rosacea a few weeks after the second dose.  Patient had never had rosacea prior.
Aside from fever, vomiting, aches and pains I had severe sciatic pain on my right side. It was so painful that I started a Medrol Dose Pac which helped by Day 3. I started that on September 2.
Information has been received from a 25 year old female with no medical history and drug allergy who was vaccinated with her second dose of GARDAIL (lot number not provided) on an unspecified date. There was no concomitant medication. Subsequently, the patient experienced off white discharge after having her period. She noticed that 2-3 months after she started getting a discharge along with pain in her lower abdomen. She performed laparoscopic test. Because of the experience the patient decided she would not get her third dose of the series. The patient sought unspecified medical attention. Additional information hs been requested.
This spontaneous report as received from a licensed practical nurse, reporting on a female patient of unknown age. Medical history and concurrent conditions were not reported. The patient was vaccinated with GARDASIL (dose, lot number and expiration date were not reported) intramuscular route. Patient received first dose of GARDASIL on 01-OCT-2013, second dose on 01-MAY-2014, and would received her third dose on 03-SEP-2014. No known adverse effects. Additional information has been requested.
had 5 nosebleeds in the past 2 weeks; This is a spontaneous report from a contactable physician (patient). A 53-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0140 and expiry date: unknown), via an unspecified route of administration on the left arm, on 21Dec2020 10:00 at a single dose for COVID-19 immunization. Medical history included asthma and hypertension. Concomitant medication included acetylsalicylic acid (ASPIRIN), atorvastatin, benazepril hydrochloride, hydrochlorothiazide (LOTENSIN HCT), and verapamil. The patient previously took cefuroxime axetil (CEFTIN) and experienced allergy. Patient had 5 nosebleeds in the past 2 weeks on 29Dec2020 12:00, after not having a single one for 10+ years. Nasal saline and Afrin was given as treatment for the event. Outcome of the event was not recovered.
IRREGULAR HEART BEAT; STAGE 1 HYPERTENSION/HEADACHE/LIGHTHEADEDNESS; FEELING LITTLE BIT CLOUDY AND CONFUSION; This spontaneous report received from a patient concerned a 77 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included non-alcohol user, and non-smoker, and other pre-existing medical conditions included the patient had no known allergies and did not had drug abuse or illicit drug use.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 206A21A expiry: UNKNOWN) dose was not reported, administered on 05-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-MAY-2021, the subject experienced feeling little bit cloudy and confusion. On 06-MAY-2021, the subject experienced irregular heart beat. On 06-MAY-2021, the subject experienced stage 1 hypertension/headache/lightheadedness. Laboratory data included: Blood pressure (NR: not provided) HYPERTENSION. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from irregular heart beat, stage 1 hypertension/headache/lightheadedness, and feeling little bit cloudy and confusion. This report was non-serious.
Info has been received from a physician concerning a 9 year old male who was vaccinated with a dose varicella virus vaccine live as a child at another physician's office. Subsequently, the pt developed chickenpox, less than 50 lesions which had crusted over. Unspecified medical attention had been sought. At the time of this report, the pt was recovering. No product quality complaint was involved. Additional info has been requested.
Swollen Tongue; Tingling lips; A metallic taste in the mouth; This spontaneous case was reported by a patient and describes the occurrence of SWOLLEN TONGUE (Swollen Tongue), PARAESTHESIA ORAL (Tingling lips) and DYSGEUSIA (A metallic taste in the mouth) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010821A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced SWOLLEN TONGUE (Swollen Tongue), PARAESTHESIA ORAL (Tingling lips) and DYSGEUSIA (A metallic taste in the mouth). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Swollen tongue, Tingling lips and Taste metallic, at an unspecified dose and frequency. At the time of the report, SWOLLEN TONGUE (Swollen Tongue), PARAESTHESIA ORAL (Tingling lips) and DYSGEUSIA (A metallic taste in the mouth) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.
Immediately dizzy and almost passed out several times. Maybe slight arrhythmia within minutes, could be from nervousness. But absolutely had serious arrhythmia starting that night. I think there may be a connection because I had bad arrhythmia when I had covid in 7/2020.   Adverse effects could be from having Covid year prior. My arrhythmia comes and goes every few months then stops On its own after a few days. When I believe I had covid in 7/2020, I went to the hospital complaining of shortness of breath, arrhythmia, chest pain. My SPO2 was in the upper 70?s and lower 80?s during the day and while trying to sleep. I was shaking from lack of oxygen. Went to hospital and I think the activity of walking around helped. Once I got to the hospital and spoke with a doctor, they told me it was sleep apnea VERY condescendingly and sent me home. No covid test. Went several times over the last year for various tests
Swollen glands in neck at collarbone, arm pit and groin area upon awaking on day three.  All swollen glands were on the side the injection was given, and are visible to the naked eye. Physician advise taking Benadryl and consult them in 24 hours if effects continue.  First dose side effects were shaking, rapid heart rate, and lethargic, lasting 2 weeks. These side effects were not present with second vaccine at this time.
Vasculitis, chilblains, scleroderma, vascular neuropathy, psoriasis, urticaria, myositis a year and a half of hell, lost mobility-walking aids, severe constipation, iron deficient anemia, muscle stiffness
right armpit is swollen up like a half size baseball protruding out of her armpit; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), on 23May2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete, unknown manufacturer), for COVID-19 Immunization. The following information was reported: SWELLING (non-serious) with onset May2022, outcome "unknown", described as "right armpit is swollen up like a half size baseball protruding out of her armpit".  Additional information: It was reported as serious: no, PQC present: no. Reporter declined a safety report. Reporter received her booster dose on Monday, and her right armpit was swollen up like a half size baseball protruding out of her armpit and she would like to know if this related to the vaccine or if there was a follow up medical care relative to it. Swollen lymph nodes (lymphadenopathy) were also reported and generally improved within 10 days. The report was not related to a study or programme. COVID-19 Booster manufacturer was unspecified. NDC number of COVID-19 Booster was unknownReason for no lot number: of COVID-19 Booster was reported as reporter unwilling to complete the report.Expiry Date of COVID-19 Booster was unknown.  The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received.
I had my vaccination on 09/16/2022. On 03/14/2023 I started to have a sore throat and under the weather. On 03/17/2023 I was COVID-19 positive and I was prescribed PAXLOVID. I do feel better on 03/21/2023 and I am still testing COVID-19 positive.
improperly stored PROQUAD was administered to one patient on an unspecified date.; No adverse effect reported.; This spontaneous report was received from a medical assistant regarding a patient of unknown age and gender. There was no information provided regarding the patient's concomitant medication, pertinent medical history and drug reactions/allergies.   On an unspecified date, one dose of improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot number R030794 and expiration date 22-APR-2020, dose and route were unknown by the reporter) was administered to the patient for prophylaxis. it was reported that the sterile diluent (DILUENT MRK INJ) used to reconstitute the vaccine was stored properly. The temperature excursion was of 6 Fahrenheit degrees to 14 Fahrenheit degrees (11 Fahrenheit) during a time frame of 8 hours. There was a previous temperature excursion of 6 Fahrenheit degrees to 14 Fahrenheit degrees (6.7 Fahrenheit) during a time frame of 4 hours. The call was because of a data logger. There was no adverse events reported.
1/2 hour after shot; flu like symptoms along with aching joints that got worse as next 5 days went by. Glands in neck swelled up on day 6.  Left arm swelling up and knot appeared on day 8.  Chills and shakes when laying down on day 12.  Dose #2 scheduled for Jan. 26.
Arm  started to swell up around injection site; Arm  is warm to touch; Diarrhea; Vomiting; A spontaneous report was received from a 61 year old female nurse who was participating in the mRNA-1273 Emergency Use Program and experienced diarrhea, vomiting, and arm started to swell up around injection site and was warm to touch.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 29 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot 026L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On 31 Dec 2020, patient had diarrhea and vomiting lasting for 1.5 hours. On 5 Jan 2020, patient experienced arm swelling around injection site and warm to touch.   Treatment for the event included Benadryl.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events diarrhea and vomiting, were considered resolved. The outcome of the event  arm started to swell up around injection site and was warm to touch was unknown.  The reporter did not provide an assessment for the events.; Reporter's Comments: This case concerns a 61 year old female patient, who experienced non-serious unexpected events of diarrhoea, feeling hot, and non-serious expected events of vomiting and injection site swelling. The event of diarrhoea and vomiting occurred 2 day after mRNA-1273 (lot # 026L20A) administration. The event of injection site swelling and feeling hot occurred 8 days after mRNA-1273 (lot # 026L20A) administration. The treatment included Benadryl. Based on temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
ADE - hives all over my trunk, under my armpits, on my face and neck, in my eyes, and a little bit on my legs. They started on my trunk on Saturday afternoon (shot on a Friday) so I started Benadryl + Xyzol + Pepcid 3x daily. Sunday morning I woke up and they were under on my face and neck so I continued my antihistamines and then had a dose pack called in. Started the dose pack on Monday morning ; when I woke up that morning the hives were then on my eyes. Completed the dose pack  and my hives are back; they started yesterday, 12-APR.
Shingles after the first dose; This case was reported by a pharmacist via sales rep and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per vaccine indication. No patients or vaccine data was available. The pharmacist did not want provide the patient's data. The pharmacist did not consent to follow-up. This case has been linked to US2020062452, reported by the same reporter.
This spontaneous report was received from a patient of unknown age and gender regarding self. Pertinent medical history, concurrent condition and concomitant medication were not reported. On an unknown date in September 2013 the patient was vaccinated with first dose of GARDASIL injection. On an unknown date in January 2014 the patient was vaccinated with second dose in series and on an unknown date in March 2014, the patient was vaccinated with third dose in series (inappropriate schedule of vaccine administered). Additional information has been requested.
Fever 101.2, lips, nose and facial swelling; Fever 101.2, lips, nose and facial swelling; nose swelling; Fever 101.2, lips, nose and facial swelling; This 38- year-old male consumer (patient) reported for himself, received the second dose BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE lot EL9264 ), via an unspecified route of administration, on 25Feb2021 at 01:00 PM (at the age of 38-years-old) as a single dose for COVID-19 immunization, in left arm. The facility where COVID-19 vaccine was administered was at a Hospital. She has had no other vaccines in the past 4 weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Historical Vaccine included first dose of BNT162B2 on 04Feb2021 at 1:00PM for COVID-19 immunization, lot number EN5318, in left arm. Medical history and concomitant medications were not reported. The patient had no known allergies.  On 26Feb2021, she experienced fever 101.2, lips, nose and facial swelling and was hospitalized 3 days. She went to Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Treatment received included: prednisone, potassium, zyrtex, famotadine. Covid PCR test negative (04Mar2021). The outcome of the events fever 101.2, lips, nose and facial swelling was recovering. It was reported that since the vaccination, the patient had not been tested for COVID-19.
hives on wrist, then all over w/in 4hrs p/inj;seen in ER
This spontaneous report was received from a licensed Practical Nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not specified. On 13-JUN-2016, the patient was vaccinated with improperly stored VARIVAX (lot # L019128, expiry date: 27-MAY-2017, dose, strength, route, vaccination site unspecified). The temperature excursion for # lot L019128 was reported as 13.5 C for 96 hours. On an unknown date, the patient was also vaccinated with improperly stored VARIVAX (lot # L029466, expiry date: 06-AUG-2017, dose, strength, route, vaccination site unspecified). The temperature excursion for # lot L029466 was reported as -13.5 C for 16 hours. Digital data logger was involved. There was no previous temperature excursion. No adverse events were reported. Product quality complaint (PQC) was not involved. Additional information has been requested.
hives on chin then reacting like pimple, sore & oozing x 1wk;
C/o hard knot at the site and radiating redness on the arm. Did not seek medical treatment or advice.
no fever, became congested; thought to be asthma, SOB, cough, dx w/pertussis;
2in in diameter raised reddened area w/itching @ site of inj (deltoid) transient dizziness for approx 15min;pulse-100 n/c of of dyspnea or chest tightness;med prescribed x 1;localized rxn lasted 3 days;
pt recv 2nd dose of vax 17OCT95 & a titer drawn on 19JAN96 showed a negative antibody response;no further details were provided;
High fever and aches for six days. Went to see family MD on 9/21/2009 and Dr. put her on 12 days of PREDNISONE (reducing dosage).
Several people were noticeable ill in my place of employment. I started out with scratchy throat, cough, fever, diarrhea, I took a home COVID-19 test that came back positive quickly. I called my doctor and was advised to quarantine from the family and to COVID-19 protocol. It took me until day 13 to finally get over the symptoms, I do have a lingering cough and some congestion.
Tender injection site; Mildly swollen injection site; Erythema (redness) which was a size of an egg at the injection site; Itching injection site; Itching from her arm to the right side of her neck; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Tender injection site), VACCINATION SITE SWELLING (Mildly swollen injection site), VACCINATION SITE ERYTHEMA (Erythema (redness) which was a size of an egg at the injection site), VACCINATION SITE PRURITUS (Itching injection site) and PRURITUS (Itching from her arm to the right side of her neck) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE PAIN (Tender injection site), VACCINATION SITE SWELLING (Mildly swollen injection site), VACCINATION SITE ERYTHEMA (Erythema (redness) which was a size of an egg at the injection site), VACCINATION SITE PRURITUS (Itching injection site) and PRURITUS (Itching from her arm to the right side of her neck). At the time of the report, VACCINATION SITE PAIN (Tender injection site), VACCINATION SITE SWELLING (Mildly swollen injection site), VACCINATION SITE ERYTHEMA (Erythema (redness) which was a size of an egg at the injection site), VACCINATION SITE PRURITUS (Itching injection site) and PRURITUS (Itching from her arm to the right side of her neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
1st dose in Sept-2022, 2nd dose not given; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 57-year-old male patient who received HAB (Twinrix adult) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Twinrix adult  (received 1st dose on 29th September 2022).   On an unknown date, the patient did not receive the 2nd dose of Twinrix adult and Twinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Twinrix adult and Twinrix Pre-Filled Syringe Device, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 9-Dec-2022 Reporter's comment: The reporter reported that it had been more than 30 days since the 1st dose of the series. No additional information was provided. Not all information was available.  Lot and expiry date of the vaccine was unknown because it was administered at a different location. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose of Twinrix adult, which led to incomplete course of vaccination.
Plantar fasciitis had just about resolved and then after shot #2, symptoms became much, much worse with nerve pain, increased pain, longer lasting pain. This started the night of my second shot. Second shot was on 4/22/2021 (first shot 4/1). As of 5/24 it still has not resolved despite multiple different types of treatment. It has not even gotten back to the point it was just before shot #2 (I was still feeling symptoms but it wasn't too bad).
Patient reported pink color, slightly raised, and warm spot around injection site on 1//15/21 (9 days after vaccination).
Acute crying episode - cried almost 3 hours continuously after injection. Thigh (injection site) slightly swollen.
Became aware of this individual when noted that she met the definition of a Vaccine Breakthrough Case. Tested Covid + >14 days after receiving 2nd Covid vaccine. She is a resident of a Long Term Care Facility who reported that she tested Covid negative on 3/8/21 but was experiencing diarrhea so brought to Hospital on 3/9/21 where she was Covid tested again and was +. Was hospitalized at that time.
Rotateq vaccine given to pt who was 8 months, 6 days old.